Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both — Marc A. Pfeffer (2003) | RDL Network
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
Article 2003 en
Authors
MP
Marc A. Pfeffer
JM
John J.V. McMurray
EV
Eric J. Velazquez
Abstract
1 min read
Valsartan is as effective as captopril in patients who are at high risk for cardiovascular events after myocardial infarction. Combining valsartan with captopril increased the rate of adverse events without improving survival.
Alessandra Meris, Maria Amigoni, Hajime Uno, Jens Jakob Thune, Anil Verma, Lars Køber, Mikhail Bourgoun, John J.V. McMurray, E. J. Velazquez, Aldo Maggioni, Jalal K. Ghali, J. Malcolm O. Arnold, S. Zelenkofske, Michael Pfeffer, Scott D. Solomon
Scott D. Solomon, John J.V. McMurray, Eric J. Velazquez, A Harsányi, Jean-Lucien Rouleau, Aldo Maggioni, Lars Køber, Harvey D. White, Frans Van de Werf, Karen S. Pieper, Robert M. Califf, Marc A. Pfeffer
Judith Meadows, John J.V. McMurray, Lars Køber, Robert M. Califf, Sergei Varshavsky, Eric J. Velazquez, Aldo Maggioni, Marc A. Pfeffer, Scott D. Solomon
Jens Jakob Thune, James Signorovitch, Lars Køber, Eric J. Velazquez, John J.V. McMurray, Robert M. Califf, Aldo Maggioni, Jean L. Rouleau, Jonathan G. Howlett, Steven L. Zelenkofske, Marc A. Pfeffer, Scott D. Solomon
Discussion(0)
No comments yet. Be the first to comment.